In recent years, the Myelopathy.org Student Society conducted a national education survey to assess Degenerative Cervical Myelopathy (DCM) education received by our future doctors in medical school. This was inspired by the top research priority identified by RECODE-DCM: raising awareness.…
Principal Investigator Dr Mark Kotter and Co-Principal Investigator Dr Ben Davies are excited to announce the launch of the first regenerative medicine trial for Degenerative Cervical Myelopathy (DCM) at Cambridge University Hospitals. RECEDE-Myelopathy is a phase 3, double blind, randomised…
Myelopathy.org is receiving entries for its inaugural research award for best piece of research aligned with a RECODE-DCM Top 10 Research Priority: Raising Awareness of Degenerative Cervical Myelopathy (DCM) Natural History Diagnostic Criteria Assessment and Monitoring Biological Basis Peri-Operative Rehabilitation Novel…
Hey, Jamie here! I’m a medical student in my 5th year at Cambridge University and the new President of the Myelopathy.org Student Society. I’ve personally been involved in Degenerative Cervical Myelopathy (DCM) research for over a year, and I have assembled a committee of…
By Max Butler Edited by Ben Davies Delayed diagnosis is a major issue for myelopathy patients (Davies et al, 2018) as delays can be distressing for sufferers, and the condition is likely to worsen without treatment. On top of this,…
Why was this study conducted? Edited by BM Davies Previous research¹ has demonstrated that patients with cervical myelopathy undergo an immune response. Additionally, proinflammatory proteins, called cytokines, are more present in cerebrospinal fluid in patients with cervical myelopathy and low…
Edited by B. Davies WHO: Researchers at the University of Southern California have conducted some exciting new myelopathy research WHAT: The researchers have developed and validated a screening test for myelopathy WHY: In medicine there are 2 types of tests:…